Besides the CSC properties of CD90+ cells in these cancers, CD90 expression has also been observed in stromal cells (e.g. mesenchymal stem cells, cancer-associated fibroblasts, and endothelium) of various cancers, and plays an important role in disease progression [26], [27], [28]. This evidence concerns the gene THY1 and cancer.